astemizole has been researched along with Basophilic Leukemia, Acute in 2 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fischer, MJ | 2 |
Paulussen, JJ | 2 |
Horbach, DA | 1 |
Roelofsen, EP | 1 |
van Miltenburg, JC | 1 |
de Mol, NJ | 2 |
Janssen, LH | 2 |
2 other studies available for astemizole and Basophilic Leukemia, Acute
Article | Year |
---|---|
Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antigens; Astemizole; beta-N-Acetylhexosaminidases; Cal | 1995 |
Dual effect of the anti-allergic astemizole on Ca2+ fluxes in rat basophilic leukemia (RBL-2H3) cells: release of Ca2+ from intracellular stores and inhibition of Ca2+ release-activated Ca2+ influx.
Topics: Animals; Anti-Allergic Agents; Astemizole; Barium; Calcium; Calcium Channels; Exocytosis; Leukemia, | 1998 |